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Summary 
Interleukin 12 (IL-12) facilitates the generation of a T helper type 1 (Thl) response, with high 
interferon 3' (IFN-3') production, while inhibiting the generation of IL-4-producing Th2 calls 
in polyclonal cultures of both human and murine T cells and in vivo in the mouse. In this study, 
we analyzed the effect of IL-12, present during cloning of human T cells, on the cytokine profile 
of the clones. The culture system used allows growth of clones from virtually every T cell, and 
thus excludes the possibility that selection of precommitted Th cell precursors plays a role in 
determining characteristics of the clones. IL-12 present during the cloning procedures endowed 
both CD4 + and CD8 + clones with the ability to produce IFN-3" at levels severalfold higher 
than those observed in clones generated in the absence of IL-12. This priming was stable because 
the high levels of IFN-3' production were maintained when the clones were cultured in the absence 
of IL-12 for 11 d. The CD4 + and some of the CD8 + clones produced variable amounts of IL-4. 
Unlike IFN-3', IL-4 production was not significantly different in clones generated in the presence 
or absence of IL-12. These data suggest that IL-12 primes the done progenitors, inducing their 
differentiation to high IFN-3'-producing clones. The suppression of IL-4-producing cells observed 
in polyclonally generated T  cells in vivo and in vitro in the presence of IL-12 is not observed 
in this donal model, suggesting that the suppression depends more on positive selection of non- 
IL-4-producing cells than on differentiation of individual clones.  However,  antigen-specific 
established Th2 clones that were unable to produce IFN-3, with any other inducer did produce 
IFN-3" at low but significant  levels when stimulated with IL-12 in combination with specific 
antigen or insoluble anti-CD3 antibodies. This induction of IFN-3' gene expression was transient, 
because culture of the established clones with IL-12 for up to 1 wk did not convert them into 
IFN-3" producers when stimulated in the absence of IL-12. These results suggest that Th clones 
respond to IL-12 treatment either with a stable priming for IFN-3' production or with only 
a transient low level expression of the IFN-3" gene, depending on their stage of differentiation. 
ecent work from our and other laboratories  (1-5)  has 
shown that human CD4 + Th cell clones, in analogy 
to the murine system (6, 7), can be subdivided into at least 
three distinct functional subsets based on their cytokine secre- 
tion profile. One type of CD4 § done (Thl) produces IL-2, 
IFN-3`, and TNF-j3, but not IL-4 or IL-5; a second type (Th2) 
produces IL-4 and IL-5,  but not IL-2, IFN-3`,  or TNF-B; 
R. Manetti and F. Gerosa contributed equally  to this work. 
and a third type (Th0) produces both Thl- and Th2-type 
cytokines (1, 3, 5, 6). Although most CD8 + human T cell 
dones exhibit a Thl-like cytokine profile (3, 5), some CD8 + 
clones showing a Th2-1ike phenotype have also been described 
(s, 9). 
Several factors can affect the development of Thl or Th2 
responses both in vivo and in vitro. Attention has been fo- 
cused on cytokines produced by either APCs or lymphocytes. 
Thus important effects have been demonstrated for IFN-3`, 
IFN-c~, IL-12, and TGF-13 on CD4 + subset maturation by 
inducing Tbl expansion in various  systems (10-19).  Most 
1273  J. Exp.  Med. ￿9  The Rockefeller  University Press ￿9 0022-1007/94/04/1273/11 $2.00 
Volume  I79  April 1994  1273-1283 striking is the requirement for IL-4 in maturation of Th2 
cells (20-22). 
The in vitro studies with human cells have investigated 
the generation of Th clones in response to recall antigens, 
analyzing prevalently the donal expansion of in vivo primed 
memory T  cells (1,  12). Mice transgenic for the genes en- 
coding an antigen-specific TCR have been used to analyze 
the ability of naive T cells to develop into a Thl or Th2 pat- 
tern of response or to give rise to Thl or Th2 clones in re- 
sponse to antigen in different culture conditions (20-22). In 
vitro studies with transgenic mice have demonstrated that, 
at the polyclonal level, IL-12 induces the development of Thl 
CD4 § ceils by priming Th cells for efficient IFN-T produc- 
tion and preventing development of IL-4-producing cells (17, 
18,  23).  However, IL-12 did not prevent the development 
of IL-4-producing cells induced by optimal concentrations 
of IL-4,  and IL-4  significantly, although not  completely, 
prevented the priming for IFN-3' production induced by IL-12 
(18,  23). 
In vivo, IL-12 protects susceptible BALB/c mice from Le/sh- 
mania major infection (24, 25) and acts as an dtident adju- 
vant in vaccination with soluble L. major antigens (26). These 
effects of 1I.-12 are dependent on its ability to partially in- 
hibit  IL-4 production and to  significantly increase IFN-3r 
production in the infected animals, i.e., shifting the response 
from a prevalent Th2-type to the Thl-type, which is charac- 
teristic in the resistant mice strains. The probable physiologic 
role of IL-12 in the development of an ef~cient Thl response 
is suggested by the ability of anti-IL-12 antibodies in vivo 
to suppress  the natural resistance of C3H mice to L.  major 
infection (25).  In vitro,  however, IL-12 is not an absolute 
requirement for antigen-induced priming for a Thl response, 
although its presence during priming enhances the ability 
of antigen-primed Th cells to produce IFN-'y (17,  18). 
The experimental systems used to date have not permitted 
determination of whether the different cytokines affecting 
Th cell development, IL-12 in particular, induce differentia- 
tion of bipotential Th precursors or rather a selective priming 
and/or expansion of already committed Thl and Th2 precursor 
cells (10,  19, 27, 28).  This question is particularly relevant 
in the case of human studies which have analyzed donal ex- 
pansion of memory Th cells (1, 15). However, once a Thl 
or Th2 response has been established, it appears  to be rela- 
tively stable,  and no factors capable of inducing qualitative 
changes in the cytokine profile of  established murine or human 
T  cell clones have been reported. 
In this study, we analyzed the effect of IL-12 on the differen- 
tiation ofThl-, Th0-, and Th2-1ike human T cells from clones 
of resting peripheral blood T  cells and on the production 
of IL-4 and/or IFN-7 by established antigen-specific human 
T cell clones. We show that IL-12, when present during the 
cloning of human T  cells in a culture system that ensures 
donal expansion of almost every CD4 + and CD8 + cell, in- 
duced the differentiation ofdones with greatly enhanced ability 
to produce IFN-3, but with the same pattern of 11.-4 produc- 
tion observed in clones generated in cultures without IL-12. 
Once established, clones show only minimal change in their 
ability to produce IFN-3, or IL-4 throughout continuous cul- 
ture in the presence or absence of IL-12. IL-12 had no effect 
on IL-4 production by established antigen-specific Th0- and 
Th2-1ike T  cell clones in response to antigens or anti-CD3 
antibodies, but it strongly potentiated IFN-3, production by 
Thl- and Th0-1ike clones. IL-12 also induced transient ex- 
pression of IFN-3' mRNA and detectable amounts of IFN-y 
in Th2-1ike clones. Comparable effects were observed with 
CD8 + human T  cell clones. 
Mamrials and Methods 
Reagents.  PHA was purchased from Grand Island Biological 
Co.  (Grand Island, NY). Purified protein derivative (PPD) 1 of 
MFobacteriura tuberculosis and purified tetanus toxoid (TT) were ob- 
tained from Istituto Sieroterapico  e Vaccinogeno  Sclavo (Siena, Italy). 
Dermatophagoidespteronyssinus group I (Der p I) was obtained from 
Lofarma Allergeui (Milan, Italy), and 12-O-tetndecanoyl-phorbol- 
13-acetate (TPA) was from Sigma Chemical Co. (St. Louis, MO). 
Anti-CD3,  anti-CD4, and anti-CD8 mAbs were purchased from 
Ortho Pharmaceutical Corp. (Raritan, NJ) and Becton Dickinson 
& Co. (Mountain View, CA), or produced from cells obtained from 
American Type Culture Collection (ATCC; Rockville, MD). Hu- 
man recombinant Ib2 (riD2) was a generous gift of Eurocetus 
(Milan, Italy) and of Dr. T. Taguchi (Osaka University, Osaka, 
Japan). Human rill2 (Chinese hamster ovary--cell  derived) was 
provided by Dr. Start Wolf (Genetics Institute, Cambridge, MA). 
Su~ects.  PBMC  were obtained by Ficoll-Hypaque  gradient sepa- 
ration from peripheral blood of healthy volunteer donors; donors 
showing delayed-type  hypersensitivity skin reaction to PPD; atopic 
house dust mite-sensitive subjects suffering from atopic dermatitis 
and/or extrinsic asthma and showing immediate-type skin reac- 
tivity to Der p I; and HIV-l-infected  individuals. 
Generation of CD4 + and CD8 + T  Cell Clones in the Presence or 
Absence ofrlL-12.  Clonal growth of almost every T cell from pe- 
ripheral blood was obtained using a modification of the method 
described  by Moretta et al. (29). Briefly,  PBMC from healthy donors 
were cloned by limiting dilution in 96-well round-bottom tissue 
culture plates in 200/zl R.PMI 1640 medium with 10% FCS in 
the presence of 5/zg/ml PHA, and ~/-irradiated (50 Gy) autolo- 
gous PBMC (25  x  103 cells/well) and RPMI 8866 B lympho- 
blastoid ceils (12  x  103 calls/well), rill2 (2.5 ng/ml) was added 
to half of the wells. After 3 d, rlL-2 (50 U/ml final concentration) 
was added to all cultures by replenishing half of the medium (100 
/~1). After 1 wk, irradiated feeder PBMC and RPMI 8866 (25 and 
12  x  103, respectively)  cells were again added. Cultures were then 
maintained in riD2 (50 U/ml) or a combination of  rib2 and rib12 
(1 ng/ml) and fed or split as required. In the first experiment (detailed 
in Results), 1 PBMC/welI, corresponding to '~0.7 T cell/well, was 
plated and growth was observed in 38 of 88 seeded wells with Ib2 
only, whereas in wells maintained in Ib2 and 11.,12, growth was 
observed  in 48 out of 96. These data, analyzed according to Poisson 
distribution, indicate donal effldency for T cells of >80% in IL2 
and of ;>90% in IL-2 +  ID12. All the clones derived in IL2 were 
either CD4 + or CD8 +, whereas four of the IL-2 +  IIr 
clones were CD4- CDS- and not further analyzed. On the basis 
1 Abbreviations used in this paper: Der p 1, Dermatophagoides  pteronyssinus; 
PPD, purified  protein  derivative;  RIA, radioimmunoassay;  RT-PCIL, reverse 
transcriptase-polymerase  chain  reaction;  TPA, 12-O-tetradecanoyl-phorbol- 
13-acetate; TT, tetanus toxoid. 
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containing both CD4 + and CD8 + cells, ~20% of the wells are 
expected to contain more than one clone; because CD4 + CD8 + 
wells were excluded from the study, '~15% of the wells analyzed 
probably contained two clones, both either CD4 § or CD8 +. Most 
of the dones (34/38 IL-2-generated  and 42/48 IL-2 + IL-12-gener- 
ated) grew  sufficiently to  allow assessment of phenotype  and 
cytokine production. The clones generated and maintained in the 
presence of II~12 +  II.,2 were washed after 23 d of culture, and 
divided into two parallel sets of cultures and maintained for a fur- 
ther 11 d in I1.-12 +  IL-2 or in ID2 alone. Clones generated in 
the presence of IL.2 alone were washed after 27 d of culture, and 
divided into two parallel sets (IL-2 or IL-2 +  II.-12) and cultured 
for a further 7 d. Fig. 1 A summarizes the cloning protocol. In 
a second  experiment, PBMC were plated at 0.6 and 0.3 T cell/well. 
Cloning efficiency  was "~80% for culture in the presence of 11.,12 
and ~70% for culture in the absence of Ib12. In this second ex- 
periment, in the cultures without II.-12, anti-IIr12 mAb C8.6 (as- 
cites, 1:500) was added to neutralize any endogenously produced 
IL-12. 
Generation of Antigen-specific CD4 + T Cell Clones.  PPD-, Der 
p I-, and TT-specific T cell lines were generated as described (1, 
30).  Briefly, 106  PBMC  in  2  ml  RPMI  1640 medium  sup- 
plemented with 2 mM r-glutamine, 2  x  10 -s M 2-ME and 5% 
human serum (complete medium) were stimulated in 24-well flat- 
bottomed plates for 5 d with PPD, TT, or Der p I (10 #g/ml). 
Human riD2 (20 U/ml) was then added and cultures continued 
for an additional 9 d. Visible T blasts were resuspended in com- 
plete medium and tested for antigen slx~'ificity  before cloning. To 
assess the antigen specificity  of T cell lines, 2  x  104 T blasts were 
seeded in microphtes and cocultured for 48 h with irradiated (60 
Gy) autologous PBMC (10  s) in the presence of medium alone, 
PPD, TT, or Der p I (1 #g/ml). After a 16-h pulse with 0.5 #Ci 
[3H]thymidine (Amersham International, Amersham, UK), cul- 
tures were harvested and radioactivity measured by liquid scintilla- 
tion. To generate PPD-, TT-, or Der p I-specific T cell clones, 
T blasts obtained from antigen-specific T cell lines were seeded 
under limiting dilution conditions (0.3 cell/well) in six round- 
bottomed microwell plates containing 10  s irradiated (60 Gy) al- 
logeneic PBMC (as feeder cells) and PHA (1% vol/vol) in a final 
volume of 0.2 ml complete medium supplemented with Ib2 (20 
U/ml) and 10%  FCS (Hyclone Laboratories Inc., Logan, UT). 
Growing  microcultures were then supplemented with IL-2 (20 
U/ml) and 10  s irradiated feeder cells at weekly intervals. The an- 
tigen  specificity of T  cell clones was  assessed by measuring 
[3H]thymidine  uptake after 60-h stimulation with the appropriate 
antigen under MHC-restricted conditions (1, 30). When the stim- 
ulation index (mean cpm in cultures stimulated with APC plus 
antigen/mean cpm in cultures with APC alone)  was ;>10, responses 
were considered positive. 
Generation of CD8 § T Cell Clones  frora HIV-infected Individuals. 
CD8 + T cell clones were generated from the peripheral blood of 
HIV-infected individuals showing low proportions of CD4 + T 
cells, according to the technique of Moretta et al. (29). Briefly, 
purified T cells (mostly CD8 +) were seeded in limiting numbers 
in round-bottom microwells (0.3 cells/well) containing 10  s irradi- 
ated (50 Gy) feeder cells and 1% PHA (vol/vol) in a final volume 
of 0.2 ml complete medium. After 48 h, microcultures were sup- 
plemented with ID2 (20 U/ml) and, at weekly intervals, with 10  s 
irradiated feeder cells and ID2. Growing microcultures were ex- 
panded by repeated addition of feeder  cells and Ib2 until a number 
of  cells suitable for phenotypic and functional studies was obtained. 
Suite Phenotype of T Cell Clones.  The phenotype of T blasts 
was examined  by immtmofluoresoznce  (flow  cytometry)  using FITC- 
conjugated anti-CD3,  anti-CD4,  and anti-CD8 mAbs. 
Induction of Cytokine Production by T  Cell Clones.  To induce 
eytokine production, T cell clones were resuspended in complete 
medium to a concentration of,'~10~/ml and stimulated for 3-24 h 
with insohbilized  anti-CD3  mAb  (microtiter  well-bound,  10 
/~g/ml; no accessory  cells added) or antigen and irradiated autolo- 
gous PBMC as APC (as described  above  for antigen-specific  prolifer- 
ation) in the presence or absence of different concentrations of IL- 
12. Soluble anti-CD3 mAb (OKT3, asdtes 1:10,000) and TPA (10 
ng/ml) were also used as a maximal stimulus. Cell-free culture su- 
pernatants were collected  and stored  in aliquots  at -70~  until used. 
11.-4 and IFN-7 mRNA Expression in T Cell Clones.  IL-4  and 
IFN~ mRNA expression was evaluated  in T cell clones by reverse 
transcriptase-polymerase  chain reaction (RT-PCR). Total RNA was 
prepared from T blasts by a single step guanidium isothiocyanate- 
phenol-chloroform  extraction method. First-strand  cDNA was syn- 
thesized using 5/~g total ILNA, reverse transcriptase and oligo-dT 
primer in a final volume of 50/~1 at 42~  for 1 h. The products 
obtained were denatured and 5/~1 was used for amplification with 
specific primers for IL-4 and IFNw. PCR amplification was car- 
fled out in buffer containing 50 mM KCI, 10 mM Tris-HC1, pH 
8.3, 1.5 mM MgC12, 0.1% (wt/vol)  gelatin,  200 mM dNTP, 
2.5 U Taq polymerase (Perkin-Elmer Cetus, Norwalk, CT), and 
500 pmol of each primer. The reaction consisted of 30 cycles of 
amplification followed by a 15-rain final extension at 72~  Each 
cycle included denaturation at 95~  for 30 s, annealing at 65~ 
for 60 s and extension at 72~  for 2 min. Amplified  products were 
electrophoresed on a 1.5% agarose gel. 
Quantita~on of  lFN-,y and IL.4 in T Cell Clone Supernatant~  IFN~ 
was quantitated by radioimmunoassay  (ILIA)  using our mAbs (31) 
or a commercial  kit (Centacor Corp., Malvern, PA); II.-4 was ana- 
lyzed by ELISA (Quantikine; R & D Systems Inc., Minneapolis, 
MN). Levels  of cytokine 3 SD over those of control supernatants 
obtained by stimulation of irradiated feeder cells alone were con- 
sidered positive. 
Results 
Effect of  lL-12 Present During the Cloning Procedure on IFN-7 
and IL-4 Production by the Clones.  CD4 + and CD8 + clones 
generated in the presence or absence of IL-12 were analyzed 
for the ability to produce IFN-3' and IL-4 in response to anti- 
CD3 mAb and TPA. As shown in Fig. 1 B for eight repre- 
sentative clones,  IFN-3, levels were highly variable  among 
clones,  but the high or low IFN-3, producer phenotype of 
the clones was stable throughout repeated testing between 
days 18 and 34 of culture. At day 34 of culture, all clones 
were tested for production of both IFN-3' and IL-4 (Fig. 2 
and Tables 1 and 2).  The CD4 + and CD8 + clones gener- 
ated in the presence of IL-12 and IL-2 produced significantly 
more (eight- and threefold, respectively)  IFN-3, than those 
generated in the presence  of IL-2 only. The effect was less 
&amatic among CD8 + clones due to a higher proportion 
of high IFN-qr  producers in CD8 + than in CD4 + clones 
generated in the absence of added rlL-12. These results were 
fully confirmed in a second cloning experiment (Table 3). 
Unlike IFN-% IL-4 production by CD4 + clones was not 
affected by the presence or absence of IL-12 during cloning 
(Fig. 2 and Tables 1, 2, and 3). The very low proportion of 
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Figure  1.  Cloning protocol (A) and production oflFN-3, by represen- 
tative clones at different times of culture (B). (A) PBMC from one donor 
were plated at 1 cell/well ('~0.7 T  cell/well) and cultured as described 
in Materials and Methods. Clone groups 1-4 correspond to those analyzed 
in Table 1. (B) At the indicated time, cells from eight representative  CD4 + 
clones [O, clones generated in IL-2 only (group 1); O, clones generated 
in II.,12 +  I1,2 (group 4)] were washed and tested for IFN-3, production 
in response to anti-CD3 mAb and TPA. 
A  1200- 
1000. 
800- 
~.  6oo~ 
I 
b_  Z  400 
200" 
1200- 
1000. 
800- 
?...  600. 
I 
z  400- 
B 
..J 
200 - 
10000- 
1000. 
100- 
10 
10000- 
1000- 
,r 
100- 
CD4 +  clones 
,  T 
_o  'It!  T  z  !1 
CD8 +  clones 
IL-2  IL-2  +  IL-12 
t><3  [> 
CD4 +  clones 
CD8 +  clones 
IL-2  IL-2 +  IL-12  <3  I-4><3  D 
s 
I 
1000- 
100- 
CD4 +  clones 
￿9  ￿9  ~  ￿9 
￿9  I.￿9  ~ 
￿9  ￿9  ￿9 
o  ￿9 
o 
o 
oo 
o o 
o 
o  o  o 
%o 
o  o  o  o 
10  100  100(3 
IL-4,  pg/mI 
1000 
100 
o 
10 
o 
1  o 
CD8 +  clones 
eeo  ee￿9 
o 
I00  1000 
IL-4,  pg/ml 
Figure  2.  Production  of IFN-3~ and Ib4  by individual  CD4 +  and 
CD8 + clones in response to anti-CD3 mAb and TPA. All clones were 
harvested on day 34 of culture, washed, and stimulated in the absence of 
APC or feeder ceUs. Cell-free supernatant fluids were collected after 24 h 
and assayed IFN-~/and II.,4 by RIA and ELISA, respectively. O, clones 
generated in the presence of IL-2 only (group 1); O, clones generated in 
the presence of Ib12  +  IL-2 (group 4). 
Figure  3.  Effect  of IL-12 withdrawal or addition during culture of es- 
tablished clones on IPN-'y (A) and [I,4 (B) production. CD4 + and CD8 + 
clones were all tested at day 34 after cloning. Clones generated in the pres- 
ence oflb2 alone were cultured continuously with I1,2 alone (O, group 
I), or Ib12 was added in the last 7 d of culture (O, group 2). Clones 
generated in Ib12  +  11-,12 were cultured continuously in the presence 
of the two cytokines (A, group 4) or IL-12 was omitted during the last 
11 d of culture (A, group 3). Clones were washed free of cytokines before 
stimulation with anti-CD3 mAb and TPA for 24 h; IFN-3' and Ib4 were 
measured in the cell-free supernatant fluid. The joined dosed and open 
symbols represent the resutts with each single clone, cultured in the pres- 
ence or absence of I1,12, respectively, in the last 7 (groups !  and 2) or 
11 (groups 3 and 4) d of culture. Corresponding positions  in A  and B 
refer to the same clones. 
CD8 + dones producing IL-4 precluded analysis of any effect 
of IL-12 on their ability to produce  IL-4. 
Because the cloning protocol used allowed the donal growth 
and analysis of the large majority of peripheral blood T cells, 
1276  IL-12 Regulates  IFN-y in Th Cells Table  1.  IFN-')/ and IL-4 Production in  CD4 + Human  T  Cell Clones 
Initial  Final  No.  of 
Group  Clones*  condition  condition  clones  IFN-3,  IL-4 
mean  +  SE 
U/mI  pg/ml 
1  CD4 +  IL-2  IL-2  21  69  _+  34  399  +  133 
2  CD4 §  IL-2  IL-2+IL-12  21  101  _+  46  268  _+  99 
3  CD4 +  IL-2+IL-12  IL-2  19  493  _+  72  511  _+  187 
4  CD4 +  IL-2+IL-12  IL-2+IL-12  19  635  _+  57  220  _+  60 
Student's t test  IFN-3~  IL-4 
Comparison  Type  t  P  t  P 
Group 1 vs.  2  paired  1.42  NS*  3.14  0.005 
Group 1 vs.  3  indep.  5.47  <0.001  0.49  NS 
Group 1 vs. 4  indep.  8.70  (0.001  1.19  NS 
Group 2 vs.  3  indep.  4.65  <0.001  1.17  NS 
Group 2 vs.  4  indep.  7.31  <0.001  0.59  NS 
Group 3 vs.  4  paired  2.79  0.012  1.48  NS 
* CD4 + and CD8 + human T cell clones of groups 1-4 from the first cloning experiment (as shown in Fig. 1, A and B, groups 1 and 2 and groups 
3 and 4 are the same clones maintained in the presence of different cytokines in the final 7-11 d of culture) were stimulated with anti-CD3 mAb 
and TPA, and IFN-3, and IL-4 production was determined. 
*  p >0.05. 
Table 2.  IFN-'g and IL-4 Production in  CD8 + Human  T  Cell Clones 
Initial  Final  No.  of 
Group  Clones*  condition  condition  clones  IFN-3'  IL-4 
mean  +_  SE 
U/ml  pg/ml 
1  CD8 +  IL-2  IL-2  8  224  _+  108  17  _+  7 
2  CD8 +  IL-2  IL-2+IL-12  8  350  _+  116  25  _+  9 
3  CD8 +  IL-2+IL-12  IL-2  10  636  _+  74  34  _+  12 
4  CD8 +  IL-2 + IL-12  IL-2 + IL-12  10  597  _+  84  55  _+  24 
Student's t test  IFN-~/ 
Comparison  Type  t  P 
Group 1 vs.  2  paired  2.61  0.035 
Group 1 vs.  3  indep.  3.26  <0.001 
Group 1 vs.  4  indep.  2.78  0.012 
Group 2 vs.  3  indep.  2.17  0.044 
Group 2 vs.  4  indep.  1.77  NS* 
Group 3 vs.  4  paired  0.60  NS 
* CD8 + human T cell clones of groups 1-4 from the first cloning experiment. See legend to Table 1. 
~/, 2>O.05. 
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the donal expansion of CD4 + and, in part, CD8 + T cells 
induces a differentiation of T cells to high IFN-q,-producer 
clones and does not select or induce preferential growth of 
Thl or Th0 precursor cells already committed to the high 
IFN-q(-producer status. We therefore tested the effect of IL-12 
on the IFN-?-producer phenotype of already established 
clones. CD4 + clones generated in the presence of IL-2 alone 
did not produce significantly more IFN-~ after culture for 
1 wk in the presence of IL-12, whereas clones generated in 
the presence of IL-12 and IL-2 produced 25%  less IFN-'y 
when cultured in the absence of IL-12 for the last 11 d (Fig. 
3 A and Tables 1 and 2). IL-2-generated clones cultured in 
IL-2 and IL-12 for 1 wk also produced slightly lower levels 
of IL-4 (p =  0.005), whereas the removal of IL-12 from the 
clones established in the presence of IL-2 and IL-12 did not 
result in a significant increase in IL-4 production (Fig. 3 B 
and Tables 1  and 2).  Similar results  were obtained  with 
CD8 § cells; however, the intermediate levels of IFN-3~ pro- 
duction observed in half of the CD8 + clones generated in 
the presence  of IL-2 alone rose after 1 wk in culture with IL-12. 
Effect of It.12 with anti-CO3 Antibodies or with Specific An- 
tigens and APC on IFN-T Production in  Thl,  ThO, and Th2 
Human  T  Cell Clones.  T blasts of ten established human 
CD4 + T cell clones with defined cytokine secretion profile 
(four Thl, three Th0, and three Th2) (Fig. 4) were stimu- 
lated for 24 h with insolubilized anti-CD3 mAb and T blasts 
from six other CD4 + clones with defined antigen specificity 
(two Thl, one Th0, and three TH2) (Fig. 5) were stimu- 
lated for 24 h with specific antigen and APC. Cell cultures 
were performed  in the absence or presence of increasing con- 
centrations of IL-12 and assessed for production of IL-4, and 
IFN-3,. As shown in Figs. 4 and 5, the presence of IL-12 
had no effect on IL-4 production by all types of clones, but 
strongly increased the IFN-3, production by both Thl and 
Th0 clones, and induced small but detectable IFN-3, produc- 
tion by Th2 clones. To exclude the possibility that Th2 dones 
were already capable of producing small but undetectable 
amounts of IFN-'y and that the IL-12-mediated effect simply 
1:::  1 
0"101 
0.01JI~l~i~J~i~A 
10.001 
1  ._  O01J,  ~  ,  7 
10.001~ 
1"001 
0"10 l 
001~,  ,  L 
None 0.4  2  10 
IL-12,  ng/rnl 
100,0] 
'~176  ~"~176  .-. AZ~7 
1.0~ O"  A-~ AZ.35 
l 
I-o  AZ.23 
0.1 J  1  ~  1  O-O VA/F.77 
100.0] 
I-o  Vl,67 
0 1J I  I  I  I  O-O VL14 
100"01 
I0'01 
1"01~f~l~  O-OA-A  VA.75ER'55  I-I  VA.77 
O'lJ~  i  I  I 
None 0.4  2  10 
IL- 12.  ng/rnl 
Figure 4.  Effect of Ib12 on IL-4 and IFN-3' production by established 
Thl (top), Th0 (middle), and Th2 CD4 + human antigen-specific  T cell 
clones (bottom). Cells from the indicated clones were stimulated with in- 
sohbilized anfi-CD3 mAb and the indicated  concentrations  of II.-12 in 
the absence of APC or feeder cells. IFN-y and I1.-4 were measured in the 
ceU-free  supematant fluids after 24-h incubation by ILIA and ELISA, respec- 
tively. 
reflects increased IFN-'y production over the detection limits 
of the assay, IFN-? mRNA expression was evaluated by KT- 
PCK in two representative Th2 clones and one Th0 clone 
stimulated with anti-CD3 mAb in the absence or presence 
of IL-12. IFN-3, and IL-4 mKNA was easily detected in the 
Th0 done. Neither of the two Th2 clones expressed mRNA 
for IFN-y when stimulated with insoluble anti-CD3 mAb 
in the presence of medium alone, but both clones expressed 
it in the presence of IL-12 at 5 or more ng/ml (Fig. 6). IL-4 
mRNA was always detectable in all experimental conditions 
(Fig. 6).  IFN-3'  mRNA expression was already detectable 
at 3 h after incubation with IL-12 and disappeared by 24 h, 
when the protein product became dearly detectable in the 
Table  3.  IFN-y and IL-4 Production in CD4 + and CD8 + Human  T  Cell Clones (Second Cloning  Experimen 0 
Clones*  Conditions  No. of Clones  IFN-3,  IL-4 
mean  +_  SE 
U/ml  pg/ml 
CD4*  IL-2  +  anti-IL-12  23  46  _+  11  159  _+  69 
CD4 +  IL-2  +  IL-12  23  447  _+  42  (p <0.001)*  41  +  10  (NS)  s 
CD8 §  IL-2  +  anti-IL-12  20  59  _+  17  10  _+ 0.3 
CD8 §  IL-2  +  IL-12  15  491  _+ 33 (p <0.001)  13  _+ 3 (NS) 
* CD4 § and CD8 § human T cell clones, generated  and maintained  for 20 d in the indicated conditions,  were stimulated  with anti-CD3 and mAb 
and TPA, and  IFN-'y and  IL-4 production was determined. 
*/, for significance of the difference between clones cultured in IL-2  +  anti-IL-12  and those cultured in IL-2  +  IL-12 is reported  (Student's  t test, 
independent  samples). 
s p  >O.05. 
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Figure  5.  Cooperative  effect  of specific  antigens  and IL-12  in inducing 
IFNw production  from human  CD4 + clones. Cells from two PPD (top), 
Der p I (middle), and TT-specitic (bottom) human CD4 + clones were 
stimuhted for 24 h with the corresponding  antigen (I #g/ml) and the 
indicated  concentrations  of ID12. Irradiated  autologous  PBMC  were  used 
as APC. II.-4  and IFN-3,  were measured  in the cell-free  supematant  fluids 
by ELISA and KIA, respectively. 
T  cell clone supematants (Fig. 7). The inability of the Th2 
clones to produce IFN-3' and to accumulate IFN-qt mKNA 
in the absence of IL-12 was confirmed at both the protein 
and the mKNA level upon stimulation of the ceUs with anti- 
CD3  (100 rig/m1)  and TPA (10 ng/ml) or with TPA and 
Ca  2+ ionophore, two protocols that induce maximal stim- 
ulation of IFN-3, production in Thl and Th0 clones (not 
shown). 
We then analyzed whether the IL-12-induced production 
of IFN-3~ was due to a transient or a permanent change in 
the cytokine production profile of the Th2 dories. Two Th2 
clones that had been induced to produce IFN-'y by IL-12 and 
anti-CD3 mAh were extensively washed, cultured with IL-2 
alone for 7 d, and stimulated again with anti-CD3 mAb in 
the presence or absence of IL-12.  Th2 cells stimulated with 
anti-CD3 mAb alone no longer produced IFN-% whereas 
IFN~ production was restored in the presence of freshly added 
IL-12 (Fig.  8). 
The effect of IL-12 on the cytokine production profile of 
CD8 + T  cell  clones established  from HIV + patients was 
also  investigated.  Three  CD8 + with  a  Thl-like cytokine 
profile and  three  Th2-1ike  CD8 +  clones were  stimulated 
with anti-CD3 mAb in the presence  or absence  of IL-12. 
As shown in Fig. 9, IL-12 had no effect on IL-4 production, 
but it strongly potentiated IFN-3, production by Thl-like 
CD8 + clones and induced production of detectable amounts 
of IFN-3' by Th2-1ike  CD8 + clones. 
Discussion 
IL-12, a novel heterodimeric cytokine, was shown to be 
a potent inducer of IFN-'y, acting synergistically with IL-2 
Figure 6.  ~.r.cumulation  of mKNA for IFN-qr and IL-4, as analyzed 
by RT-PCR and agerose  dectrophoresis,  in one human  CD4  + Th0 clone 
(EK14) and two Th2 done (ER55 and EK77)  induced  for 6 h with insoh- 
bilized anti-CD3 mAb in the presence  of the indicated  concentrations  of 
Ib12. Hrst-strand cDNA was synthesized  and amplified  by PCK with 
IFN-3, and IL-4  specific  primers. After  amplification,  10 #1 of the reaction 
mixture  was removed,  analyzed  by agerose  gel electrophoresis,  and visual- 
ized by ethidinm  bromide staining. The size of the expected PCK prod- 
ucts is indicated  on the left; 8-actin mRNA amplification  was used as 
a control  for a constitutively  expressed  gene. Lane  1, @X 174 DNA/Hinf 
1 size markers. Lane  2, Th0 (EK 14) done without IL-12. Lane  3, Th2 
(ER55) done without IL-12. Lane  4, Th2 (EK55) clone with 1 ng/ml 
of Ib12. Lane  5, Th2 (EK55) clone  with 50 ng/ml of IL-12. Lane  6, Th2 
(EK77) clone  without IL-12. Lane  7, Th2 (ER77) clone with 1 ng/ml 
of II.,12. Lane  8, Th2 (ER77) done with 5 ng/ml of IL-t2. Lane  9, Th2 
(EK77) clone with 50 ng/ml of IL-12. 
and several inducing stimuli (25, 32-34). More recently, IL-12 
was found to favor the in vitro development of Thl-like 
CD4 + human T cell clones (15). The effect of IL-12 on the 
development of Thl cells has been confirmed in the murine 
system in vitro (23) and in vivo (24, 25). Both in the human 
and murine systems,  IL-12 enhances IFN-y production in 
polyclonally or clonally expanded Th cell populations and 
inhibits the priming for IL-4 production (17, 18, 23-25, 35). 
However, it has not been clear whether these effects reflect 
the action oflL-12 on Th cell precursors,  directly or through 
secretion of secondary cytokines such as IFN-y or TNF, by 
inducing a differentiation effect on single clones to produce 
the various cytokines, or rather by selectively stimulating the 
growth of IFN-3,-producing Thl cells. There is dearcut evi- 
dence that IL-12 can directly activate expression  of IFN-y 
genes in T  cells, both CD4 + and CD8 +,  and in NK cells 
(34, 36). However, there was no evidence indicating whether 
IL-12 induces a stable phenotype change in Th cells leading 
to high IFN-7 production, or instead, selects for Thl cell 
expansion when present during antigenic or mitogenic stim- 
ulation. IL-12  has a direct mitogenic effect on murine Thl 
clones ([37] and Gerhard, W., and G. Trinchieri, unpublished 
1279  Manetti  et al. Figure 7.  Kinetics of I1,12-induced IFN-3' mRNA and protein. Cells 
of the Th2 CD4 + clone B14 were stimulated with imohbilized anti-CD3 
mAb in the absence or presence of II.,12 (10 ng/ml) and at the indicated 
times of culture, IFN-3t mRNA accumulation was evaluated by RT-PCR 
(A) and IFN-~ production by RIA (B). (A) Cells were stimulated in the 
absence (lanes 2-5) or presence (lanes 6-9)  of I1,12 for 3 h (lanes 2 and 
6), 6 h (lanes 3 and 7), 12 h (lanes 5 and 8), and 24 h  (lanes 6 and 9); 
lane I shows @X 174 DNA/Hinf 1 size markers and lane 10, a positive 
control for PCR, carried out under conditions as in Fig. 6. (B) IFN-3' 
production was tested by ILIA at the indicated times in the cell-free super- 
natant fluids from B14 cells cultured in the absence (O) or presence (O) 
of I1,12. 
results) but not on Th2 clones and is a potent inducer of 
production of IFN-T, which suppresses Th2 cell prolifera- 
tion (28). Another open question is whether cytokines such 
as IL-12, which have major effects during primary and sec- 
ondary antigen priming and clone generation, can still modify 
the phenotype of established Th clones with a defined pat- 
tern of cytokine production. 
To address some of these questions, we cloned human pe- 
ripheral blood lymphocytes in the presence of PHA, IL-2, 
1  v/////~  Clone VA.74 
lTZZR Clone  ER.12 
I 
oCD3  I  aCD3+IL12  I  oCD3  I  oCD3+lkl2  I 
Not  IL-12  pre  treated  IL-12  pretreated 
Figure 8.  Transient IFN-T production induced by I1,12 in Th2-1ike 
CD4 + clones. Two Th2-1ike  clones, VA74 and ER12, were stimulated for 
24 h with insolubilized anti-CD3, alone, or with II.-12 (10 ng/ml), and 
IFN-qr production was measured. Cells treated with anti-CD3 and I1,12 
(I1,12 pretreated) were then washed, maintained in culture for 7 d in com- 
plete medium, and again stimulated with insolubilized anti-CD3 in the 
presence or absence of I1,12; IFN-3' production was measured. 
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Figure 9.  Effect  of 11.,12 on cytokine production by human CD8 + 
clones from HIV+-patients.  Cells from four Thl-like (top) and from 3 
Th-2-1ike human CD8 + clones (bottom) were stimulated with insoluble 
anti-CD3 mAb and the indicated concentrations of I1.,12 for 24 h. Cell- 
free supernatant fluids were measured for I1,4 and IFN-3' by ELISA and 
RIA, respectively. 
and feeder cells (29), conditions that allowed us to done vir- 
tually every T cell present in the initial population,  and ana- 
lyzed the effect of IL-12 present during the cloning on the 
phenotype of  the clones.  Because  irradiated feeder  cells  (PBMC 
and RPMI 8866) were present in the first week of culture 
of the clone, we cannot completely  rule out an indirect effect 
of  IL-12 on the done precursor cells, especially  since NK cells, 
contained in the feeder PBMC,  play a role in the effect of 
IL-12 on Thl cell development both in humans (15) and in 
the mouse (26). 1Io-12 might also induce production of  IFN-3, 
or other cytokines from the feeder PBMC. However, a direct 
effect of IL-12 on CD4 + cells has been demonstrated in 
TCK transgenic mice (18), suggesting  that at least part of 
the effect of IL-12 is directly on the T cell dones and their 
precursor cells in our system. It is also possible that both 
PBMC and RPMI 8866 cells, despite irradiation  and brief 
survival in our culture conditions, produce low levels of IL-12 
(38). However, addition of optimal concentrations of rlL-12 
dramatically enhanced IFN-3' production by all dones in re- 
sponse to a maximal nonspecific stimulation (anti-CD3 mAb 
and TPA), but did not significantly change IL-4 production. 
In the second doning experiment, endogenous IL-12 was neu- 
tralized using anti-IL-12 mAb: in these conditions the differen- 
tial IFN-3' production between clones generated in the pres- 
ence or absence of IL-12 was even more marked. Because all 
of the CD4 + clones generated in the presence of IL-12 were 
high IFN-'y producers whereas most of the dones generated 
in the absence of  IL-12 were nonproducers or low producers, 
and because the cloning efficiency of T cells was more than 
80%, these results dearly show that the generation of high 
IFN-3, producer clones in the presence of IL-12 reflects in- 
duced differentiation of individual clones and not selection. 
Although ,o15% of the cultures analyzed in the first experi- 
ment were expected to contain more than I clone, the pres- 
ence of few oligodonal wells would lead to an overestima- 
tion of IFN-3, producer clones in the culture without IL-12, 
because the mixture of  a low and a high producer clone would 
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weaken our conclusion. The question of whether IL-12 acts 
on Th cells through the induction of IFN-3, is controversial; 
some studies (15, 18) report on the inability of anti-IFN-3, 
antibodies  to  prevent  the  IL-12-mediated effect  on  Thl 
differentiation, whereas others indicate that IFN-'y may be 
required at least for the priming of IFN-3, production but 
not for inhibition of development of IL-4-producing cells 
(17, 24). Although IFN-3' can upregulate its own gene ex- 
pression (39), and the induced IFN-7 may play a role in some 
of the effects of IL-12,  IFN-3,  cannot replace IL-12  in in- 
ducing Thl cell development (18, 40).  Because generation 
of T  cell clones in the presence of IL-12 had no significant 
effect on IL-4 production, it is possible that while the priming 
effect for IFN-'y is a true differentiation effect of IL-12, the 
inhibition of IL-4-producing cells in polyclonal cultures or 
in vivo might be more of a selection process. It is interesting 
to note that although the IL-12 inhibition of IL-4-producing 
cells was first demonstrated in vitro in the human system 
(15), this effect is particularly evident in vivo in the L. major 
infection model (24-26), whereas in vitro IL-12 has little or 
no ability to prevent the priming for IL-4 production induced 
in the presence of IL-4 (18, 35).  It is, however, likely that 
the negative effect of IL-12 on IL-4 producing cells, observed 
in bulk cultures or in vivo, is based on a selection process 
more effective in a physiologic in vivo environment than in 
tissue culture conditions. It should be pointed out that in 
our cloning conditions containing accessory cells, low levels 
of IL-4 might have been present and had an effect on the 
ability of the clones to produce IL-4; studies testing the effect 
of adding exogenous IL-4 or neutralizing endogenous IL-4 
in our cloning conditions are in progress. 
The effect of IL-12 in inducing differentiation of the clones 
to a high IFN-'y producer phenotype was relatively stable: 
removal of IL-12 from the culture medium of the clones for 
a period of 11 d resulted in only 25% reduction of the overall 
ability of the clones to produce IFN-~. On the other hand, 
most of the dones generated in the absence of IL-12, which 
were not high IFN-3, producers, were not primed for IFN-3' 
even after culture for 1 wk in the presence of optimal con- 
centrations of IL-12. In the second cloning experiment, ad- 
dition to or removal from established clones of IL-12 for 1 
wk also did not affect the ability of the clones to produce 
IFN-3, (results not shown). These results suggest that there 
is a stage during the expansion of the Th clones in which 
cells are susceptible for priming for IFN-3, production, per- 
haps through the induction of a stable alteration in IFN-'y 
gene conformation that poises it for transcription or that 
renders it responsive to positive regulatory mechanisms. In 
established clones that display a non-IFN-3:-producing  pheno- 
type (often Th2-1ike with IL-4 production), the IFN-3' gene 
might no longer be susceptible to the priming effect of IL- 
12. Since no attempt was made to isolate T cells at distinct 
functional stages prior to limiting dilution analysis, the clones 
analyzed were likely derived from both memory and naive 
T cells. The priming/differentiative  effect of IL-12 in reducing 
high IFN-~-producing clones was observed with all clones 
and did not appear to be affected by the nature of the donal 
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T progenitor cells, although other effects of IL-12 on Th cell 
generation, e.g., selection, would likely be influenced by the 
immune status of the Th cells (10, 27). 
Because murine Thl but not Th2 clones were reported 
to respond to IL-12 with proliferation (37), it was of interest 
to investigate the direct effect of IL-12  on CD4 + T  cell 
clones with already  established cytokine profiles. IL-12 strongly 
potentiated IFN-~ production induced by anti-CD3 mAb 
or specific antigen in both Thl- and Th0-type T cell clones, 
without affecting the ability of Th0- and Th2-type clones 
to produce IL-4. More importantly, IL-12 promoted mRNA 
expression and production of detectable amounts of IFN-3' 
by Th2 clones, demonstrating that the cytokine profile of 
T cells exhibiting a well-established functional phenotype can 
be qualitatively  altered.  Previous attempts to  change the 
cytokine profile of established  CD4 + human T  cell clones 
by using different cytokines, hormones, or drugs have been 
consistently unsuccessful.  For example,  IL-4,  which is the 
dominant factor in determining the likelihood for Th2 polar- 
ization in cultured cells, had no effect on the cytokine secre- 
tion profile of Th0- or Thl-type clones  (our unpublished 
results).  However, IFN-3, production induced by IL-12 on 
Th2 clones  was a transient phenomenon, and after  IL-12 
removal, the same antigen-specific clones no longer produced 
IFN-'y in response to stimulation with anti-CD3 mAb, similar 
to the results obtained with the PHA/IL-2-induced clones. 
Nevertheless, this finding suggests that even highly polarized 
T cells can produce all types of cytokines, given the appro- 
priate microenvironmental conditions. Indeed, we recently 
found that growth transformation with herpesvirus saimiri 
induces stable and even constitutive IFN-3, production by es- 
tablished Th2-type CD4 + human T  cell clones (De Carli, 
M., E. Maggi, and S. Romagnani, manuscript in prepara- 
tion). Explanation of the paradoxical observation that IL-12 
can induce IFN-3, gene expression in Th2 clones, although 
at low levels, but fails to induce priming for subsequent IFN-3, 
on the same clones awaits information on the molecular mech- 
anisms of the priming effect. Because both transcriptional 
and posttranscriptional mechanisms are involved in induc- 
tion of IFN-3: expression by IL-12 (36), it is possible that 
different levels of regulation are involved in direct gene ex- 
pression and in priming. 
Our results also suggest that human CD8 + and CD4 + 
T cell clones are similarly regulated. Although a higher propor- 
tion of CD8 + clones than of CD4 + generated in the absence 
of IL-12 were high IFN-'y producers, a significant  effect of 
IL-12  on the generation of high IFN-3, producer CD8 + 
clones was observed and every CD8 + done generated in the 
presence of IL-12 was a high IFN-3' producer. Interestingly, 
Th2-1ike CD8 + T  cell clones were derived from both pc- 
@hera blood and skin biopsy specimens of HIV-seropositive 
patients, and the proportion of such clones was even higher 
when IL-4 was added in bulk culture before cloning (Maggi, 
E.,  and S. Romagnani, manuscript in preparation). How- 
ever, even these Th2-type CD8 + clones were induced to 
IFN-~ production when stimulated with anti-CD3 mAb in 
the presence  of IL-12. 
The present study confirms that IL-12 is a key component in the cytokine network with complex regulatory mecha- 
nisms that can not only determine the type of specific im- 
mune response at early stages of antigenic challenge, but also 
alter, at least transiently, the profile of highly polarized CD4 + 
and CD8 + T  call responses. 
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